Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Novel medication targets for the treatment of alcoholism: preclinical studies.

Rezvani AH, Lawrence AJ, Arolfo MP, Levin ED, Overstreet DH.

Recent Pat CNS Drug Discov. 2012 Aug;7(2):151-62. Review.

PMID:
22574676
2.

Cholinergic receptor system as a target for treating alcohol abuse and dependence.

Rahman S, Prendergast MA.

Recent Pat CNS Drug Discov. 2012 Aug;7(2):145-50. Review.

PMID:
22574675
4.

Carisbamate, a novel antiepileptic candidate compound, attenuates alcohol intake in alcohol-preferring rats.

Rezvani AH, Overstreet DH, Vaidya AH, Zhao B, Levin ED.

Alcohol Clin Exp Res. 2009 Aug;33(8):1366-73. doi: 10.1111/j.1530-0277.2009.00966.x. Epub 2009 Apr 30.

PMID:
19413647
5.

Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.

Rezvani AH, Slade S, Wells C, Petro A, Lumeng L, Li TK, Xiao Y, Brown ML, Paige MA, McDowell BE, Rose JE, Kellar KJ, Levin ED.

Psychopharmacology (Berl). 2010 Aug;211(2):161-74. doi: 10.1007/s00213-010-1878-8. Epub 2010 Jun 10.

6.
7.

The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system.

Cowen MS, Adams C, Kraehenbuehl T, Vengeliene V, Lawrence AJ.

Addict Biol. 2005 Sep;10(3):233-42.

PMID:
16109584
8.

Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment.

Overstreet DH, Rezvani AH, Cowen M, Chen F, Lawrence AJ.

Addict Biol. 2006 Sep;11(3-4):356-73. Review.

PMID:
16961764
9.

Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats.

Rezvani AH, Overstreet DH, Levin ED, Rosenthal DI, Kordik CP, Reitz AB, Vaidya AH.

Alcohol Clin Exp Res. 2007 Jan;31(1):57-63.

PMID:
17207102
10.

Pharmacotherapies for alcoholism: the old and the new.

Olive MF.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):2-4.

PMID:
20232494
11.

Medications and alcohol craving.

Swift RM.

Alcohol Res Health. 1999;23(3):207-13. Review.

PMID:
10890816
12.

Pharmacological treatment of alcohol dependence: a review of the evidence.

Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT.

JAMA. 1999 Apr 14;281(14):1318-25.

PMID:
10208148
13.

Pharmacotherapy of alcohol dependence: a review of the clinical data.

Mann K.

CNS Drugs. 2004;18(8):485-504. Review.

PMID:
15182219
14.

Treatment of alcohol dependence: recent progress and reduction of consumption.

Testino G, Leone S, Borro P.

Minerva Med. 2014 Dec;105(6):447-66. Review.

PMID:
25392958
15.

Drugs for relapse prevention of alcoholism: ten years of progress.

Spanagel R, Kiefer F.

Trends Pharmacol Sci. 2008 Mar;29(3):109-15. doi: 10.1016/j.tips.2007.12.005. Epub 2008 Feb 11.

PMID:
18262663
16.

Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence.

Barron S, Lewis B, Wellmann K, Carter M, Farook J, Ring J, Rogers DT, Holley R, Crooks P, Littleton J.

Recent Pat CNS Drug Discov. 2012 Aug;7(2):129-44. Review.

PMID:
22574674
17.

Preclinical and clinical pharmacology of alcohol dependence.

Tambour S, Quertemont E.

Fundam Clin Pharmacol. 2007 Feb;21(1):9-28. Review. Erratum in: Fundam Clin Pharmacol. 2007 Apr;21(2):215.

PMID:
17227441
18.

Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism.

Lin RC, Guthrie S, Xie CY, Mai K, Lee DY, Lumeng L, Li TK.

Alcohol Clin Exp Res. 1996 Jun;20(4):659-63.

PMID:
8800381
19.

The state of pharmacotherapy for the treatment of alcohol dependence.

Garbutt JC.

J Subst Abuse Treat. 2009 Jan;36(1):S15-23; quiz S24-5. Review.

PMID:
19062347
20.

JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats.

Galici R, Rezvani AH, Aluisio L, Lord B, Levin ED, Fraser I, Boggs J, Welty N, Shoblock JR, Motley ST, Letavic MA, Carruthers NI, Dugovic C, Lovenberg TW, Bonaventure P.

Psychopharmacology (Berl). 2011 Apr;214(4):829-41. doi: 10.1007/s00213-010-2092-4. Epub 2010 Nov 18.

PMID:
21086115

Supplemental Content

Support Center